$11.41
+5.96 (+109.36%)
USD · as of 2026-08-19 · marketstack
Clinical trials
catalyst calendar across sponsors →Studies where TNON is the lead sponsor, as filed with ClinicalTrials.gov. Completion dates are the sponsor's own projected windows and are revised as a study runs. Active studies first, then completed and stopped — newest readout first within each.
2 interventional
Held by 0 tracked-famous managers · FINRA short interest 1.0 days to cover (settled 2026-07-31) · government filings 180d: none disclosed
| Study | Phase | Status | Interventions | Conditions | Enrollment | Primary completion | Updated |
|---|---|---|---|---|---|---|---|
| Post-Market Feasibility Study of the Tenon Medical CATAMARAN™ SI Joint Fusion SystemNCT05633888Proportion of subjects that meet the definition of Subject Success at 6 months post-procedureOpen-label · Other | Not applicable | Unknown status | Device: CATAMARAN SI Joint Fusion System | Sacroiliac Joint Disruption, Degenerative Sacroiliitis | 50 | Jan 2025 | 2024-03-20 |
| Tenon Medical CATAMARAN™ SI Joint Fusion System CT Scan StudyNCT05628142Radiographic FusionOpen-label · Other | Not applicable | Unknown status | Radiation: Pelvic CT Scan | Sacroiliac Joint Disruption, Degenerative Sacroiliitis | 50 | Nov 2024 | 2023-04-21 |
Primary completion is the date the sponsor filed with the registry — their own projection, revised whenever they revise it, unless the row is marked actual.
Source: ClinicalTrials.gov, retrieved 2026-08-19